Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |